Christopher M DeGiorgio

Summary

Affiliation: University of California
Country: USA

Publications

  1. ncbi Trigeminal nerve stimulation for epilepsy
    Christopher M DeGiorgio
    Department of Neurology, Geffen School of Medicine at UCLA, Los Angeles, USA
    Neurology 61:421-2. 2003
  2. ncbi Neurocysticercosis in the United States: review of an important emerging infection
    Christopher M DeGiorgio
    Neurology 64:1486; author reply 1486. 2005
  3. ncbi n-3 fatty acids (fish oil) for epilepsy, cardiac risk factors, and risk of SUDEP: clues from a pilot, double-blind, exploratory study
    Christopher M DeGiorgio
    Department of Neurology, David Geffen School of Medicine at UCLA, Los Angeles, CA 90095, USA
    Epilepsy Behav 13:681-4. 2008
  4. ncbi Pilot study of trigeminal nerve stimulation (TNS) for epilepsy: a proof-of-concept trial
    Christopher M DeGiorgio
    UCLA Department of Neurology, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA
    Epilepsia 47:1213-5. 2006
  5. ncbi Sero-prevalence of Taenia solium cysticercosis and Taenia solium taeniasis in California, USA
    C DeGiorgio
    Department of Neurology, David Geffen School of Medicine, UCLA, Los Angeles, CA, USA
    Acta Neurol Scand 111:84-8. 2005
  6. ncbi Trigeminal nerve stimulation: seminal animal and human studies for epilepsy and depression
    Christopher M DeGiorgio
    Department of Neurology, David Geffen School of Medicine at UCLA, Los Angeles, CA 90095, USA
    Neurosurg Clin N Am 22:449-56, v. 2011
  7. ncbi Vagus nerve stimulation for epilepsy: randomized comparison of three stimulation paradigms
    C DeGiorgio
    UCLA Geffen School of Medicine, Los Angeles, CA, USA
    Neurology 65:317-9. 2005
  8. ncbi RMSSD, a measure of vagus-mediated heart rate variability, is associated with risk factors for SUDEP: the SUDEP-7 Inventory
    Christopher M DeGiorgio
    Department of Neurology, David Geffen UCLA School of Medicine, Los Angeles, CA 90095, USA
    Epilepsy Behav 19:78-81. 2010
  9. ncbi Atrial flutter/atrial fibrillation associated with lacosamide for partial seizures
    Christopher M DeGiorgio
    Department of Neurology, School of Medicine, University of California at Los Angeles, Los Angeles, CA 90095, USA
    Epilepsy Behav 18:322-4. 2010
  10. ncbi Trigeminal nerve stimulation in major depressive disorder: first proof of concept in an open pilot trial
    Lara M Schrader
    David Geffen School of Medicine at UCLA, Los Angeles, CA 90095, USA
    Epilepsy Behav 22:475-8. 2011

Collaborators

Detail Information

Publications13

  1. ncbi Trigeminal nerve stimulation for epilepsy
    Christopher M DeGiorgio
    Department of Neurology, Geffen School of Medicine at UCLA, Los Angeles, USA
    Neurology 61:421-2. 2003
  2. ncbi Neurocysticercosis in the United States: review of an important emerging infection
    Christopher M DeGiorgio
    Neurology 64:1486; author reply 1486. 2005
  3. ncbi n-3 fatty acids (fish oil) for epilepsy, cardiac risk factors, and risk of SUDEP: clues from a pilot, double-blind, exploratory study
    Christopher M DeGiorgio
    Department of Neurology, David Geffen School of Medicine at UCLA, Los Angeles, CA 90095, USA
    Epilepsy Behav 13:681-4. 2008
    ....
  4. ncbi Pilot study of trigeminal nerve stimulation (TNS) for epilepsy: a proof-of-concept trial
    Christopher M DeGiorgio
    UCLA Department of Neurology, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA
    Epilepsia 47:1213-5. 2006
    ..Four (57%) of seven subjects who completed >or=3 months experienced a >or=50% reduction in seizure frequency. The results of this pilot study support further investigation into the safety and efficacy of TNS for epilepsy...
  5. ncbi Sero-prevalence of Taenia solium cysticercosis and Taenia solium taeniasis in California, USA
    C DeGiorgio
    Department of Neurology, David Geffen School of Medicine, UCLA, Los Angeles, CA, USA
    Acta Neurol Scand 111:84-8. 2005
    ..solium Taeniasis in an at-risk community in the USA, specifically rural Southern California; identify T. solium Taeniasis positive individuals, and treat positive individuals for the tapeworm T. solium Taeniasis...
  6. ncbi Trigeminal nerve stimulation: seminal animal and human studies for epilepsy and depression
    Christopher M DeGiorgio
    Department of Neurology, David Geffen School of Medicine at UCLA, Los Angeles, CA 90095, USA
    Neurosurg Clin N Am 22:449-56, v. 2011
    ..In humans thus far the technique has been applied noninvasively, and is termed external trigeminal nerve stimulation (eTNSTM)...
  7. ncbi Vagus nerve stimulation for epilepsy: randomized comparison of three stimulation paradigms
    C DeGiorgio
    UCLA Geffen School of Medicine, Los Angeles, CA, USA
    Neurology 65:317-9. 2005
    ..The results indicate that the three duty-cycles were equally effective. The data support the use of standard duty-cycles as initial therapy...
  8. ncbi RMSSD, a measure of vagus-mediated heart rate variability, is associated with risk factors for SUDEP: the SUDEP-7 Inventory
    Christopher M DeGiorgio
    Department of Neurology, David Geffen UCLA School of Medicine, Los Angeles, CA 90095, USA
    Epilepsy Behav 19:78-81. 2010
    ..The goal of this study was to determine if specific measures of heart rate variability (HRV) are associated with the total score on a new seven-item inventory for sudden unexplained death in epilepsy (SUDEP)...
  9. ncbi Atrial flutter/atrial fibrillation associated with lacosamide for partial seizures
    Christopher M DeGiorgio
    Department of Neurology, School of Medicine, University of California at Los Angeles, Los Angeles, CA 90095, USA
    Epilepsy Behav 18:322-4. 2010
    ..The literature regarding LCM-related cardiac death and arrhythmia is discussed. Physicians should be aware of the potential cardiac effects of this novel antiepileptic drug...
  10. ncbi Trigeminal nerve stimulation in major depressive disorder: first proof of concept in an open pilot trial
    Lara M Schrader
    David Geffen School of Medicine at UCLA, Los Angeles, CA 90095, USA
    Epilepsy Behav 22:475-8. 2011
    ..This novel neuromodulation approach may have use as an adjunct to pharmacotherapy in major depressive disorder. Additional larger trials are needed to delineate efficacy and tolerability with greater reliability...
  11. ncbi Acute and long-term safety of external trigeminal nerve stimulation for drug-resistant epilepsy
    Juliana Pop
    Department of Neurology, Olive View Internal Medicine Program, UCLA School of Medicine, Los Angeles, CA 90095, USA
    Epilepsy Behav 22:574-6. 2011
    ..The data indicate that eTNS of the infraorbital and supraorbital branches of the trigeminal nerve is safe and well tolerated...
  12. ncbi Deaths associated with cysticercosis. Report of three cases and review of the literature
    Christopher M DeGiorgio
    Department of Neurology, University of California, Los Angeles, California 91342, USA
    Neurosurg Focus 12:e2. 2002
    ..The most common causes of death appear to be 1) intracranial hypertension in surgically treated patients and 2) shunt infection...
  13. ncbi Vagus nerve stimulation therapy, epilepsy, and device parameters: scientific basis and recommendations for use
    Christi Heck
    USC Department of Neurology, Keck School of Medicine, University of Southern California, Los Angeles, California, USA
    Neurology 59:S31-7. 2002
    ..Finally, we provide an algorithm for the adjustment of VNS device settings (see Appendices)...